Login
Agenda
9 - 12 March 2010
ISICEM International Symposium on Intensive Care and Emergency Medicine - Brussels (Belgium)
9 -11 June 2010
EACTA European Association of Cardiothoracic Anaesthesiologists - Edinburgh (UK)
12-15 June 2010
ESA European Society of Anaesthesiology - Helsinki (Finland)
18-22 September 2010
ERS European Respiratory Society - Barcellona (Spain)
9 -13 October 2010
ESICM European Society of Intensive Care Medicine - Barcellona (Spain)
> International events
| COMPARISON OF BRONCHOSCOPIC BRONCHOALVEOLAR LAVAGE VS BLIND LAVAGE WITH A MODIFIED NASOGASTRIC TUBE |
|
|
|
| Monday, 21 July 2008 | |
|
Leo A, Galindo-Galindo J, Folch E, Guerrero A, Bosques F, Mercado R, Arroliga AC. Hospital Universitario Dr. José Eleuterio González. Monterrey. México. Med Intensiva. 2008 Apr;32(3):115-120.
OBJECTIVE: Our objective was to compare the results of a blind lavage vs a bronchoscopic-guided bronchoalveolar lavage for the etiologic diagnosis of ventilator-associated pneumonia (VAP).
DESIGN: Prospective study in consecutive patients with high probability of VAP. Every patient underwent both procedures, in a formally randomized fashion. The interpretation of quantitative cultures was done in a blind fashion.
SETTING: Single center study, with a 20 bed medical and surgical Intensive Care Unit of the University Hospital in Monterrey, Mexico.
PATIENTS: Twenty-five patients with high probability of VAP.
INTERVENTIONS: Every patient underwent blind bronchoalveolar lavage with a modified nasogastric tube, and a bronchospic-guided bronchoalveolar lavage.
RESULTS: Twenty-one patients underwent both procedures. Four patients were excluded due to contamination of the cultures. The quantitative cultures were compared in a paired fashion. Only two patients had discordant cultures. The correlation coefficient between the number of colonies was very high, r = 0.90 (95% confidence interval [CI], 0.77-0.96; p = 0.0001).
CONCLUSIONS: The blind bronchoalveolar lavage with a modified nasogastric tube is a valuable tool for the identification of etiologic agent in VAP, particularly when trained bronchoscopists or the necessary resources for bronchoscopic-guided bronchoalveolar lavage are not readily available. |
|
| Last Updated ( Monday, 28 July 2008 ) |
| < Prev | Next > |
|---|
![]() |
| Select and watch from the following webinars |












